Printer Friendly
The Free Library
14,718,639 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Genentech Names Mark Ahn Vice President, Hematology Sales and Marketing.


Business Editors

SOUTH SAN FRANCISCO South San Francisco, city (1990 pop. 54,312), San Mateo co., W Calif.; inc. 1908. South San Francisco has several industrial parks; its manufactures include medical supplies and equipment, foods, paint, paper products, consumer goods, and clothing. , Calif.--(BUSINESS WIRE)--Jan. 28, 2002

Genentech, Inc. (NYSE NYSE

See: New York Stock Exchange
: DNA DNA: see nucleic acid.
DNA
 or deoxyribonucleic acid

One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes.
) today announced the appointment of Mark Ahn to vice president, Hematology Sales and Marketing. Ahn will report to Myrtle Potter, executive vice president of Commercial Operations and chief operating officer Chief Operating Officer (COO)

The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president.
.

In his position, Ahn, 39, is responsible for all commercial activities, including sales and marketing, of the company's hematology franchise, including Rituxan(R) (rituximab) for non-Hodgkin's lymphoma.

"Mark's extensive biotechnology and pharmaceutical experience will be an asset to Genentech's Commercial organization," said Potter. "I'm confident that he will help Genentech continue to build its hematology franchise, an important and promising area of our business."

Prior to joining Genentech, Ahn was senior director of immunology sales for Bristol-Myers Squibb (BMS). In addition, he led the Secure the Future initiative, a $100 million commitment by Bristol-Myers Squibb to provide care and support for women and children living with HIV/AIDS HIV/AIDS Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome  in sub-Saharan Africa. Before that Ahn was responsible for strategic planning for international operations, and worked with Japan and China operations. Prior to BMS, he was at Amgen Inc. where he served as General Manager, Amgen Greater China and held positions in strategy, general management, sales and marketing, business development and finance. Ahn also served as an officer in the U.S. Army.

Ahn holds a bachelor's degree in history/economics and a master's of business administration in finance from Chaminade University. He was a graduate fellow in economics at Essex University, and has a doctorate in business administration from the University of South Australia.

Genentech, Inc., is a leading biotechnology company that discovers, develops, manufactures and markets human pharmaceuticals for significant unmet medical needs. Fifteen of the currently approved products of biotechnology are based on or stem from Genentech science. Genentech markets ten products directly in the United States. The company has headquarters in South San Francisco, California South San Francisco is a city in San Mateo County, California, United States, located on the San Francisco Peninsula in the San Francisco Bay Area. The population was 60,552 at the 2000 census.  and is traded on the New York Stock Exchange New York Stock Exchange (NYSE)

World's largest marketplace for securities. The exchange began as an informal meeting of 24 men in 1792 on what is now Wall Street in New York City.
 under the symbol DNA.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jan 28, 2002
Words:325
Previous Article:F-Secure Warns of New Worm, MyParty, That Gives a Whole New Meaning to 'Dot Com'.
Next Article:New Astigmatic Lenses Make the Heidelberg Retina Tomograph II Easier to Use and More Comfortable for Patients.
Topics:



Related Articles
Sharon Tetlow Named Vice President & Chief Financial Officer at Terrapin Technologies.
Roche to Publicly Sell 20 Million Genentech Shares, Genentech Board Approves 2-For-1 Stock Split.
Genentech Appoints Myrtle Potter to EVP of Commercial Operations and COO.
Profit Slide.(UNUMProvident Corp. sells asset to Allstate Life Insurance Co.)(Brief Article)
Genentech Appoints Kimberly Popovits Senior Vice President, Marketing and Sales, for CardioPulmonary and Specialty Markets.
Schwarz Pharma's Rights to Growth Hormone Products Reacquired by Genentech; Schwarz Pharma to Focus on Central Nervous System and Urology.
WAR INJUSTICE CORRECTED; ATHLETE HONORED 57 YEARS LATE.(News)
Genentech Reports 22 Percent Increase In Product Sales For First Quarter; 29 Percent Increase in Pro Forma Earnings Per Share.
This month in agri marketing ...(For Openers)(Brief Article)
Horiba Steps Up Production in China with Completion of Second Plant.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles